Risk factors for Alzheimer: Towards prevention?;Facteurs de risque de la maladie d'Alzheimer: Vers une prévention?

Presse Medicale

Volumn 35, Issue 9 II, 2006, Pages 1309-1316

  Vogel, Thomas ^a   Benetos, Athanase ^b   Verreault, René ^c   Kaltenbach, Georges ^a   Kiesmann, Michèle ^a   Berthel, Marc ^a  

^a Ctr de Gerontologie des Hop Univ   (France)

^b CHU NANCY BRABOIS   (France)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; CARDIOVASCULAR RISK; COGNITIVE THERAPY; DIABETES MELLITUS; DIETARY INTAKE; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; INTERVENTION STUDY; LEISURE; LONGITUDINAL STUDY; OBESITY; PHYSICAL ACTIVITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

EID: 33748663550     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(06)74810-2     Document Type: Review

References (65)

1. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology. 2002; 58: 1175-81.
2. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002; 156: 445-53.
3. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005; 642: 277-81.
4. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000; 21: 49-55.
5. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001; 322: 1447-51.
6. Qiu C, Winblad B, Viitanen M, Fratiglioni L. Pulse Pressure and Risk of Alzheimer Disease in Persons Aged 75 Years and Older: a Community-Based, Longitudinal Study. Stroke. 2003; 34: 594-9.
7. Vogel T, Verreault R, Kaltenbach G, Berthel M. L'hypertension artérielle est-elle associée à la maladie d'Alzheimer. Press Med. 2005; 18; 34: 809-12.
8. Petitti DB, Crooks VC, Buckwalter JG, Chiu V. Blood pressure levels before dementia. Arch Neurol. 2005; 62: 112-16.
9. Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol. 2001; 58: 1640-6.
10. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998; 352: 1347-51.
11. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S et al. Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002; 162: 2046-52.
12. in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001; 22: 407-12.
13. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S et al. PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003; 163: 1069-75.
14. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B et al. The study on cognition and prognosis in the elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertension. 2004; 22: 1605-12.
15. Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurolol Sciences. 2005; 229-30: 151-55.
16. Hanon O, Forette F. Prevention of dementia: lessons from SYST-EUR and PROGRESS. J Neurol Sci. 2004; 226: 71-4.
17. Yasar S, Corrada M, Brookmeyer R, Kawas C. Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 2005; 26: 157-63.
18. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999; 53: 1937-42.
19. Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 2004; 63: 1902-7.
20. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology. 2004; 63: 1181-6.
21. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004; 61: 661-6.
22. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol. 2001; 154: 635-41.
23. Curb JD, Rodriguez BL, Abbott RD, Petrovitch H, Ross GW, Masaki KH et al. Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology. 1999; 52: 971-5.
24. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology. 2004; 63: 1187-92.
25. Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M et al. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003; 163: 1053-7.
26. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet. 2000; 356: 1627-31.
27. Rockwood K, Kirkland S, Hogan DB, MacKnight C, Merry H, Verreault R et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol. 2002; 59: 223-7.
28. Zandi PP, Sparks DL, Khachaturian AS, Tschanz J, Norton M, Steinberg M et al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry. 2005; 62: 217-24.
29. Rea TD, Breitner JC, Psaty BM, Fitzpatrick AL, Lopez OL, Newman AB et al. Stalin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol. 2005; 62: 1047-51.
30. Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol. 2002; 59: 1258-63.
31. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997; 42: 776-82.
32. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003; 60: 940-6.
33. Barberger-Gateau P, Letenneur L, Deschamps V, Peres K, Dartigues JF, Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ. 2002; 325: 932-3.
34. Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A, Witteman JC et al. Diet and risk of dementia: Does fat matter? The Rotterdam Study. Neurology. 2002; 59: 1915-21.
35. Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ. Omega-3 Fatty Acids and Risk of Cognitive Impairment and Dementia. Journal of Alzheimer's Disease. 2003; 5: 315-22.
36. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of body mass index and risk for Alzheimer's disease. Arch Intern Med. 2003; 163: 1524-8.
37. Rosengren A, Skoog I, Gustafson D, Wilhelmsen L. Body Mass Index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med. 2005; 165: 321-6.
38. Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M. Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc. 1994; 42: 933-6.
39. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology. 2001; 56: 1188-94.
40. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino Rb et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002; 346: 476-83.
41. Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998; 351: 1840-3.
42. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci L et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology. 1999; 52: 78-84.
43. Tyas SL, White LR, Petrovitch H, Webster Ross G, Foley DJ, Heimovitz HK et al. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study Neurobiol Aging. 2003; 24: 589-96.
44. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol. 1997; 153: 185-92.
45. Mukamal KJ, Kuller LH, Fitzpatrick AL, Longstreth WT Jr, Miltleman MA, Siscovick DS. Prospective study of alcohol consumption and risk of dementia in older adults. JAMA. 2003; 289: 1405-13.
46. Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. Alcohol intake and risk of Alzheimer's disease. J Am Geriatr Soc. 2004; 52: 540-46.
47. Truelsen T, Thudium D, Gronbaek M. Copenhagen City Heart Study. Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology. 2002; 59: 1313-9.
48. Ruitenberg A, van Swieten JC, Witteman JC, Mehta KM, van Duijn CM, Hofman A et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet. 2002; 359: 281-6.
49. in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med. 2001; 345: 1515-21.
50. Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ. 2003; 327: 128-33.
51. De Craen AJ, Gussekloo J, Vrijsen B, Westendorp RG. Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am J Epidemiol. 2005; 161: 114-20.
52. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998; 279: 688-95.
53. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996; 348: 429-32.
54. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997; 48: 1517-21.
55. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS et al. WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289: 2651-62.
56. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002; 287: 3223-9.
57. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC et al. Cache County Memory Study Investigators. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002; 288: 2123-9.
58. Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol. 2003; 60: 203-8.
59. Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol. 2004; 159: 959-67.
60. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001; 58: 498-504.
61. Abbott RD, White LR, Ross GW, Masaki KH, Curb JD, Petrovitch H. Walking and dementia in physically capable elderly men. JAMA. 2004; 292: 1447-53.
62. Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, Kuslansky G et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med. 2003; 348: 2508-16.
63. Rovio S, Kareholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol. 2005; 4: 705-11.
64. Wilson RS, Mendes De Leon CF, Barnes LL, Schneider JA, Bienias JL et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002; 287: 742-8.
65. De la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann N Y Acad Sci. 2002; 977: 196-215.